DIVERSIMMUNE Trademark

Trademark Overview

On Thursday, April 6, 2017, a trademark application was filed for DIVERSIMMUNE with the United States Patent and Trademark Office. The USPTO has given the DIVERSIMMUNE trademark a serial number of 87401492. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 6, 2024. This trademark is owned by Abpro Corporation. The DIVERSIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

[ Research services using a platform of biological research tools and techniques to speed development of different monoclonal antibodies; ] custom design and engineering of antibodies
diversimmune

General Information

Serial Number87401492
Word MarkDIVERSIMMUNE
Filing DateThursday, April 6, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 6, 2024
Registration Number5421788
Registration DateTuesday, March 13, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and Services[ Research services using a platform of biological research tools and techniques to speed development of different monoclonal antibodies; ] custom design and engineering of antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 13, 2017
Primary Code042
First Use Anywhere DateTuesday, November 17, 2015
First Use In Commerce DateTuesday, November 17, 2015

Trademark Owner History

Party NameAbpro Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAbpro Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAbpro Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Tuesday, February 6, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 6, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 6, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 15, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, March 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Thursday, April 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 11, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 11, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 10, 2017NEW APPLICATION ENTERED

Related Keywords

diversimmune antibodies research monoclonal different custom engineering design development speed using